GHRP-2 - 5mg

SPECIFICATIONS

Product Code: GR2005

Sequence: D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2

Molecular Formula: C45H55N9O6

Molecular Weight: 817.9749 g/mol

CAS: 158861-67-7

Purity: Technical / Research Grade 98%

Other details: No TFA Salt

Form: Lyophilized powder

Color: White

Storage temperature: -20°C

Source: Synthetic

Safety classification: Standard handling

DESCRIPTION

GHRP-2 (Growth Hormone–Releasing Peptide-2) is a synthetic hexapeptide that functions as a selective agonist of the ghrelin receptor (GHS-R1a). It is structurally related to other growth hormone secretagogues and is widely used in experimental research settings. In laboratory models, GHRP-2 is studied for its interaction with receptor-mediated signaling pathways associated with endocrine communication and pituitary regulatory processes. Its activity is linked to mechanisms involved in hormonal signaling coordination and system-wide physiological regulation.

As a ghrelin receptor agonist, GHRP-2 activates intracellular signaling cascades associated with receptor binding, including pathways involved in cellular communication, regulatory coordination, and endocrine system signaling. GHRP-2 is also investigated in research contexts focused on signaling interactions between endocrine pathways, neuroendocrine regulation, and integrative physiological processes across multiple tissue systems.

Due to its defined receptor selectivity and well-characterized signaling profile, GHRP-2 remains a relevant compound in experimental models exploring growth hormone–related signaling pathways and endocrine regulatory mechanisms.

REFERENCES

All observations described above originate from in vitro systems, animal studies, or other preclinical experimental models. They are intended solely to support basic research into molecular, cellular, and physiological mechanisms and do not imply therapeutic, diagnostic, or preventive applications in humans or animals.

L.T. Phung et al., "The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine" [PubMed]

R. Hu et al., "Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation" [Plos One]

D. Yamamoto et al., "GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1" [PubMed]

G. Muccioli et al., "Growth hormone-releasing peptides and the cardiovascular system" [PubMed]

P. Zeng et al., "Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice" [PubMed]

B. Laferrère et al., "Obese Subjects Respond to the Stimulatory Effect of the Ghrelin Agonist Growth Hormone-Releasing Peptide-2 on Food Intake" [PMC]

A. Moulin et al., "Recent Developments in Ghrelin Receptor Ligands" [Chemistry Europe]

V. Bodart et al., "Identification and Characterization of a New Growth Hormone–Releasing Peptide Receptor in the Heart" [AHA Journal]

D.D Taub et al., "Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways" [PubMed]

DISCLAIMER

This product is intendend for lab research and development use only. These studies are performed outside of the body. This product is not medicines or drugs and has not been approved by the FDA or EMA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.

All product information provided on this website is for informational and educational purposes only.